Guideline or statement
Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association
- Scientific statement
Recommendations
As issued by the authors
Personalized therapy based on: (1) identification of the specific cardiac pathophysiology; (2) determination of the root cause so that, if applicable, cause-specific treatment can occur (precision medicine); (3) therapies based on the patient's clinical milieu
Clinical milieus: at risk (phenotype negative), asymptomatic (phenotype positive), symptomatic, and end-stage cardiomyopathy
Special emphasis on cause-specific therapies in children for prevention and attenuation of cardiomyopathy in addition to symptomatic treatments
Original publication
Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association. Circulation. Published 8 June 2023. doi:10.1161/cir.0000000000001151
Summarised from the published abstract; every number is checked against it